12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Rytary regulatory update

FDA extended the PDUFA date by 3 months for an NDA from Impax for Rytary extended-release carbidopa/levodopa to treat idiopathic Parkinson's disease (PD). The new date is Jan. 21, 2013; it was Oct....

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >